STOCK TITAN

Form 144: Cencora Insider to Sell 1,000 Shares via Goldman Sachs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Cencora, Inc. (symbol: COR) has filed a Form 144 with the U.S. Securities and Exchange Commission, indicating a proposed insider sale of common stock under Rule 144.

The notice covers the potential disposition of 1,000 common shares through broker Goldman Sachs & Co. LLC. The sale is tentatively scheduled for 18 June 2025 on the NYSE. At a stated aggregate market value of $293,200, the implied reference price is roughly $293.20 per share.

The filing shows the shares were originally granted to the seller as restricted stock awards on two dates—20 Aug 2013 (500 shares) and 09 Aug 2016 (500 shares)—as part of compensation from Cencora. No prior sales have been reported in the past three months, and the person filing affirms no knowledge of undisclosed material adverse information about the company.

Relative to the total outstanding share count of 193,823,487, the proposed sale represents approximately 0.0005 % of shares outstanding, suggesting minimal dilution or market impact. The filing is routine in nature, providing transparency around a small insider transaction rather than signaling any broader strategic change.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine insider Form 144; 1,000-share sale (~$293k) is immaterial versus 194 M shares outstanding—neutral for valuation.

The proposed transaction equals roughly half of one-thousandth of one percent of Cencora’s float and does not alter fundamental supply–demand dynamics. No concurrent negative disclosures are referenced, and the seller certifies absence of undisclosed adverse information. The filing therefore appears administrative, with no discernible impact on earnings outlook, liquidity, or capital structure.

TL;DR: Standard Rule 144 compliance; shows insider following proper disclosure channels—governance positive but financially neutral.

Form 144 signals management’s adherence to SEC transparency requirements. While investors often monitor insider activity for sentiment clues, this scale of sale is far below thresholds that would raise governance or control concerns. The absence of recent insider sales and the certification of no undisclosed MNPI (material non-public information) underpin good governance practices.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many Cencora (COR) shares are being proposed for sale in this Form 144 filing?

The filing covers 1,000 common shares of Cencora, Inc.

What is the aggregate market value of the proposed Cencora share sale?

The aggregate market value stated is $293,200.

When is the approximate sale date for the Cencora shares under Form 144?

The approximate date of sale disclosed is June 18, 2025.

Which broker will execute the proposed Cencora (COR) share sale?

The broker listed is Goldman Sachs & Co. LLC, 200 West Street, New York, NY 10282.

How large is the proposed sale relative to Cencora’s total shares outstanding?

The 1,000 shares equal about 0.0005 % of the 193,823,487 shares outstanding—an immaterial amount.

Were these Cencora shares acquired through open-market purchases or compensation?

All 1,000 shares were restricted stock awards granted as compensation in 2013 and 2016.
Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

68.38B
185.78M
4.2%
94.03%
3.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN